Cohera Medical wins FDA panel date for TissuGlu surgical adhesive

Cohera Medical says the FDA plans to convene its General & Plastic Surgery advisory panel to review a bid for pre-market approval of Cohera's TissuGlu surgical adhesive.

Cohera Medical said it's won a date with an FDA advisory panel in August for its TissuGlu surgical adhesive.

Cohera Medical Inc., Food & Drug Administration (FDA)

News Well, Pre-Market Approval (PMA), Regulatory/Compliance, Surgical, Tissue sealer

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/Ur58yW